Literature DB >> 19361477

Disturbances in the secretion of neurotransmitters in IA-2/IA-2beta null mice: changes in behavior, learning and lifespan.

T Nishimura1, A Kubosaki, Y Ito, A L Notkins.   

Abstract

Islet-associated protein 2 (IA-2) and IA-2beta are major autoantigens in type 1 diabetes and transmembrane proteins in dense core secretory vesicles (DCV) of neuroendocrine cells. The deletion of these genes results in a decrease in insulin secretion. The present study was initiated to test the hypothesis that this deletion not only affects the secretion of insulin, but has a more global effect on neuroendocrine secretion that leads to disturbances in behavior and learning. Measurement of neurotransmitters showed that norepinephrine, dopamine and 5-HT were significantly decreased in the brain of double knockout (DKO) mice (P<0.05 to <0.001). In tests evaluating anxiety-like behavior and conditioned-learning, the DKO mice showed a highly significant increase in anxiety-like behavior (P<0.01 to <0.001) and impairment of conditioned learning (P<0.01) as compared to WT mice. The DKO mice also displayed an increase in spontaneous and induced seizures (P<0.01) and age-related death. Contrary to the generally held view that IA-2 and IA-2beta are expressed exclusively in DCV, subcellular fractionation studies revealed that IA-2beta, but not IA-2, co-purifies with fractions rich in synaptic vesicles (SV), and that the secretion of dopamine, GABA and glutamate from the synaptosomes of the DKO mice was significantly decreased as was the number of SV (P<0.01). Taken together, these findings show that IA-2beta is present in both DCV and SV, and that the deletion of IA-2/IA-2beta has a global effect on the secretion of neurotransmitters. The impairment of secretion leads to behavioral and learning disturbances, seizures and reduced lifespan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361477      PMCID: PMC2672562          DOI: 10.1016/j.neuroscience.2009.01.022

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

1.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Centrifugal precipitation chromatography: principle, apparatus, and optimization of key parameters for protein fractionation by ammonium sulfate precipitation.

Authors:  Y Ito
Journal:  Anal Biochem       Date:  2000-01-01       Impact factor: 3.365

3.  Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion.

Authors:  Keiichi Saeki; Min Zhu; Atsutaka Kubosaki; Jingping Xie; Michael S Lan; Abner Louis Notkins
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

4.  Expression of the protein tyrosine phosphatase-like protein IA-2 during pancreatic islet development.

Authors:  C Roberts; G A Roberts; K Löbner; M Bearzatto; A Clark; E Bonifacio; M R Christie
Journal:  J Histochem Cytochem       Date:  2001-06       Impact factor: 2.479

5.  Phenylarsine oxide inhibits alpha-latrotoxin-stimulated [3H]GABA release from rat brain synaptosomes.

Authors:  M V Linetska; L G Storchak; N H Himmelreich
Journal:  Neurochem Int       Date:  2003-06       Impact factor: 3.921

6.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

Authors:  John F Cryan; Olivia F O'Leary; Sung-Ha Jin; Julie C Friedland; Ming Ouyang; Bradford R Hirsch; Michelle E Page; Ashutosh Dalvi; Steven A Thomas; Irwin Lucki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

7.  Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.

Authors:  Luis Pennanen; Hans Welzl; Patrizia D'Adamo; Roger M Nitsch; Jürgen Götz
Journal:  Neurobiol Dis       Date:  2004-04       Impact factor: 5.996

8.  Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.

Authors:  Atsutaka Kubosaki; Steffen Gross; Junnosuke Miura; Keiichi Saeki; Min Zhu; Shinichiro Nakamura; Wiljan Hendriks; Abner Louis Notkins
Journal:  Diabetes       Date:  2004-07       Impact factor: 9.461

9.  Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.

Authors:  P Achenbach; E Bonifacio; A J K Williams; A G Ziegler; E A M Gale; P J Bingley
Journal:  Diabetologia       Date:  2008-01-09       Impact factor: 10.122

10.  Increase in drug-induced seizure susceptibility of transgenic mice overexpressing GABA transporter-1.

Authors:  Wen-Juan Zhao; Ying-Hua Ma; Jian Fei; Zhen-Tong Mei; Li-He Guo
Journal:  Acta Pharmacol Sin       Date:  2003-10       Impact factor: 6.150

View more
  19 in total

Review 1.  Signaling from the secretory granule to the nucleus.

Authors:  Chitra Rajagopal; Richard E Mains; Betty A Eipper
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-08       Impact factor: 8.250

2.  Deletion of the secretory vesicle proteins IA-2 and IA-2beta disrupts circadian rhythms of cardiovascular and physical activity.

Authors:  Soo Mi Kim; Andrea Power; Timothy M Brown; Cara M Constance; Steven L Coon; Takuya Nishimura; Hiroki Hirai; Tao Cai; Christoph Eisner; David R Weaver; Hugh D Piggins; David C Klein; Jürgen Schnermann; Abner L Notkins
Journal:  FASEB J       Date:  2009-05-11       Impact factor: 5.191

3.  Deletion of Ia-2 and/or Ia-2β in mice decreases insulin secretion by reducing the number of dense core vesicles.

Authors:  T Cai; H Hirai; G Zhang; M Zhang; N Takahashi; H Kasai; L S Satin; R D Leapman; A L Notkins
Journal:  Diabetologia       Date:  2011-07-06       Impact factor: 10.122

4.  A microRNA negative feedback loop downregulates vesicle transport and inhibits fear memory.

Authors:  Rebecca S Mathew; Antonis Tatarakis; Andrii Rudenko; Erin M Johnson-Venkatesh; Yawei J Yang; Elisabeth A Murphy; Travis P Todd; Scott T Schepers; Nertila Siuti; Anthony J Martorell; William A Falls; Sayamwong E Hammack; Christopher A Walsh; Li-Huei Tsai; Hisashi Umemori; Mark E Bouton; Danesh Moazed
Journal:  Elife       Date:  2016-12-21       Impact factor: 8.140

5.  The Ia-2β intronic miRNA, miR-153, is a negative regulator of insulin and dopamine secretion through its effect on the Cacna1c gene in mice.

Authors:  Huanyu Xu; Liron Abuhatzira; Gilberto N Carmona; Suryakiran Vadrevu; Leslie S Satin; Abner L Notkins
Journal:  Diabetologia       Date:  2015-07-04       Impact factor: 10.122

6.  Pathophysiologic changes in IA-2/IA-2β null mice are secondary to alterations in the secretion of hormones and neurotransmitters.

Authors:  Tao Cai; Abner L Notkins
Journal:  Acta Diabetol       Date:  2015-04-11       Impact factor: 4.280

7.  A genomewide linkage scan of cocaine dependence and major depressive episode in two populations.

Authors:  Bao-Zhu Yang; Shizhong Han; Henry R Kranzler; Lindsay A Farrer; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

8.  Disruption of gene expression rhythms in mice lacking secretory vesicle proteins IA-2 and IA-2β.

Authors:  Sohan Punia; Kyle K Rumery; Elizabeth A Yu; Christopher M Lambert; Abner L Notkins; David R Weaver
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-11       Impact factor: 4.310

9.  Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2 β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain.

Authors:  W Mandemakers; L Abuhatzira; H Xu; L A Caromile; S S Hébert; A Snellinx; V A Morais; S Matta; T Cai; A L Notkins; B De Strooper
Journal:  Diabetologia       Date:  2013-04-18       Impact factor: 10.122

10.  IA-2 modulates dopamine secretion in PC12 cells.

Authors:  Takuya Nishimura; Shin-Ichi Harashima; Hu Yafang; Abner Louis Notkins
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.